Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
The MHRA's Yellow Card scheme is the UK's pharmacovigilance system for reporting suspected adverse drug reactions (ADRs)
Ice packs and cooling cases are allowed in carry-on bags for medication storage
Behavioural support : NHS-funded weight management programmes offer structured support including dietary advice, physical activity guidance, and behavioural strategies
The decision may depend on: Which medication and formulation you are considering
Fact: Letrozole and GLP-1s There is a significant amount of misinformation online regarding how these drugs interact
